Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Other Non-Current Assets (2022 - 2025)

Gossamer Bio's Other Non-Current Assets history spans 4 years, with the latest figure at $408000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 44.17% year-over-year to $408000.0; the TTM value through Dec 2025 reached $408000.0, up 44.17%, while the annual FY2025 figure was $408000.0, 44.17% up from the prior year.
  • Other Non-Current Assets reached $408000.0 in Q4 2025 per GOSS's latest filing, roughly flat from $407000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.3 million in Q2 2022 to a low of $59000.0 in Q2 2024.
  • Average Other Non-Current Assets over 4 years is $569250.0, with a median of $615500.0 recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: plummeted 92.34% in 2024, then soared 549.15% in 2025.
  • A 4-year view of Other Non-Current Assets shows it stood at $680000.0 in 2022, then decreased by 9.12% to $618000.0 in 2023, then tumbled by 54.21% to $283000.0 in 2024, then skyrocketed by 44.17% to $408000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Other Non-Current Assets are $408000.0 (Q4 2025), $407000.0 (Q3 2025), and $383000.0 (Q2 2025).